Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir

Autor:	Christophe Moreno, John McNally, Evguenia S. Svarovskaia, Krishna Chodavarapu, Jonas Schreiber
Rok vydání:	2016
Předmět:	Adult Male medicine.medical_specialty Sofosbuvir Genotype Hepatitis C virus Hepacivirus medicine.disease_cause Gastroenterology Sofosbuvir/velpatasvir Antiviral Agents Heterocyclic Compounds 4 or More Rings 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans 030212 general & internal medicine Hepatology biology business.industry Hepatitis C biology.organism_classification medicine.disease Virology Regimen Drug Combinations 030211 gastroenterology & hepatology Carbamates business medicine.drug
Zdroj:	Hepatology (Baltimore, Md.). 64(3)
ISSN:	1527-3350
Popis:	During a phase 3 study evaluating the combination of sofosbuvir-velpatasvir for 12 weeks in patients with genotype 1, 2, 4, 5, and 6 hepatitis C virus (HCV) infection, we enrolled a patient who was subsequently found to be infected with genotype 7 HCV. This patient tolerated the study regimen well and achieved sustained virological response 12 weeks after treatment (SVR12). (Hepatology 2016;64:983-985).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104d848a0e17778fc8aac1fa04370c64 https://pubmed.ncbi.nlm.nih.gov/27177605 Zobrazit plný text záznamu Plný text